378 related articles for article (PubMed ID: 27412422)
21. The impact of abuse and mood on bowel symptoms and health-related quality of life in irritable bowel syndrome (IBS).
Kanuri N; Cassell B; Bruce SE; White KS; Gott BM; Gyawali CP; Sayuk GS
Neurogastroenterol Motil; 2016 Oct; 28(10):1508-17. PubMed ID: 27151081
[TBL] [Abstract][Full Text] [Related]
22. Internet survey on the actual situation of constipation in the Japanese population under 70 years old: focus on functional constipation and constipation-predominant irritable bowel syndrome.
Kawamura Y; Yamamoto S; Funaki Y; Ohashi W; Yamamoto K; Ozeki T; Yamaguchi Y; Tamura Y; Izawa S; Hijikata Y; Ebi M; Ogasawara N; Sasaki M; Kasugai K
J Gastroenterol; 2020 Jan; 55(1):27-38. PubMed ID: 31428873
[TBL] [Abstract][Full Text] [Related]
23. [The prevalence of irritable bowel symptoms in a population of shopping mall visitors in Santiago de Chile].
Madrid-Silva AM; Defilippi-Caffri C; Landskron-Ramos G; Olguín-Herrera F; Reyes-Ponce A; Castro-Lara A; Larraín-Corp S; Martínez-Roje N; Cortés-Espinoza J
Rev Gastroenterol Mex; 2013; 78(4):203-10. PubMed ID: 24290320
[TBL] [Abstract][Full Text] [Related]
24. Increased psychological distress and somatization in patients with irritable bowel syndrome compared with functional diarrhea or functional constipation, based on Rome IV criteria.
Shiha MG; Asghar Z; Thoufeeq M; Kurien M; Ball AJ; Rej A; Tai FWD; Afify S; Aziz I
Neurogastroenterol Motil; 2021 Oct; 33(10):e14121. PubMed ID: 33719130
[TBL] [Abstract][Full Text] [Related]
25. The impact of overlapping functional dyspepsia, belching disorders and functional heartburn on anxiety, depression and quality of life of Chinese patients with irritable bowel syndrome.
Yao X; Yang Y; Zhang S; Shi Y; Zhang Q; Wang Y
BMC Gastroenterol; 2020 Jul; 20(1):209. PubMed ID: 32631285
[TBL] [Abstract][Full Text] [Related]
26. Impact of upper digestive symptoms in patients with irritable bowel syndrome.
Balboa A; Mearin F; Badía X; Benavent J; Caballero AM; Domínguez-Muñoz JE; Garrigues V; Piqué JM; Roset M; Cucala M; Figueras M;
Eur J Gastroenterol Hepatol; 2006 Dec; 18(12):1271-7. PubMed ID: 17099375
[TBL] [Abstract][Full Text] [Related]
27. Irritable bowel syndrome: prevalence, risk factors in an adult Lebanese population.
Chatila R; Merhi M; Hariri E; Sabbah N; Deeb ME
BMC Gastroenterol; 2017 Dec; 17(1):137. PubMed ID: 29197339
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic Yield of Colonoscopy in Patients With Symptoms Compatible With Rome IV Functional Bowel Disorders.
Asghar Z; Thoufeeq M; Kurien M; Ball AJ; Rej A; David Tai FW; Afify S; Aziz I
Clin Gastroenterol Hepatol; 2022 Feb; 20(2):334-341.e3. PubMed ID: 32882424
[TBL] [Abstract][Full Text] [Related]
29. The epidemiology and quality of life of functional gastrointestinal disorders according to Rome III vs Rome IV criteria: A cross-sectional study in primary care.
Chuah KH; Beh KH; Mahamad Rappek NA; Mahadeva S
J Dig Dis; 2021 Mar; 22(3):159-166. PubMed ID: 33595169
[TBL] [Abstract][Full Text] [Related]
30. Differentiation of functional constipation and constipation predominant irritable bowel syndrome based on Rome III criteria: a population-based study.
Koloski NA; Jones M; Young M; Talley NJ
Aliment Pharmacol Ther; 2015 May; 41(9):856-66. PubMed ID: 25736433
[TBL] [Abstract][Full Text] [Related]
31. Frequency and risk factors of functional gastro-intestinal disorders in a rural Indian population.
Ghoshal UC; Singh R
J Gastroenterol Hepatol; 2017 Feb; 32(2):378-387. PubMed ID: 27262283
[TBL] [Abstract][Full Text] [Related]
32. The impact of psychiatric and extraintestinal comorbidity on quality of life and bowel symptom burden in functional GI disorders.
Vu J; Kushnir V; Cassell B; Gyawali CP; Sayuk GS
Neurogastroenterol Motil; 2014 Sep; 26(9):1323-32. PubMed ID: 25070610
[TBL] [Abstract][Full Text] [Related]
33. The clinical overlap between functional dyspepsia and irritable bowel syndrome based on Rome III criteria.
Wang A; Liao X; Xiong L; Peng S; Xiao Y; Liu S; Hu P; Chen M
BMC Gastroenterol; 2008 Sep; 8():43. PubMed ID: 18808723
[TBL] [Abstract][Full Text] [Related]
34. Sex-Related Differences in Clinical Symptoms, Quality of Life, and Biochemical Factors in Irritable Bowel Syndrome.
Choghakhori R; Abbasnezhad A; Amani R; Alipour M
Dig Dis Sci; 2017 Jun; 62(6):1550-1560. PubMed ID: 28374085
[TBL] [Abstract][Full Text] [Related]
35. Splitting irritable bowel syndrome: from original Rome to Rome II criteria.
Mearin F; Roset M; Badía X; Balboa A; Baró E; Ponce J; Díaz-Rubio M; Caldwell E; Cucala M; Fueyo A; Talley NJ
Am J Gastroenterol; 2004 Jan; 99(1):122-30. PubMed ID: 14687153
[TBL] [Abstract][Full Text] [Related]
36. Prevalence and impact of irritable bowel syndrome in people with epilepsy.
Camara-Lemarroy CR; Escobedo-Zúñiga N; Ortiz-Zacarias D; Peña-Avendaño J; Villarreal-Garza E; Díaz-Torres MA
Epilepsy Behav; 2016 Oct; 63():29-33. PubMed ID: 27552483
[TBL] [Abstract][Full Text] [Related]
37. Characteristics of functional bowel disorder patients: a cross-sectional survey using the Rome III criteria.
Ford AC; Bercik P; Morgan DG; Bolino C; Pintos-Sanchez MI; Moayyedi P
Aliment Pharmacol Ther; 2014 Feb; 39(3):312-21. PubMed ID: 24308816
[TBL] [Abstract][Full Text] [Related]
38. Postinfectious and sporadic functional gastrointestinal disorders have different prevalences and rates of overlap: results from a controlled cohort study 3 years after acute giardiasis.
Wensaas KA; Hanevik K; Hausken T; Eide GE; Langeland N; Mørch K; Rortveit G
Neurogastroenterol Motil; 2016 Oct; 28(10):1561-9. PubMed ID: 27189227
[TBL] [Abstract][Full Text] [Related]
39. Evidence that independent gut-to-brain and brain-to-gut pathways operate in the irritable bowel syndrome and functional dyspepsia: a 1-year population-based prospective study.
Koloski NA; Jones M; Talley NJ
Aliment Pharmacol Ther; 2016 Sep; 44(6):592-600. PubMed ID: 27444264
[TBL] [Abstract][Full Text] [Related]
40. Prevalence and impact of Rome IV versus Rome III irritable bowel syndrome in patients with inflammatory bowel disease.
Fairbrass KM; Selinger CP; Gracie DJ; Ford AC
Neurogastroenterol Motil; 2022 May; 34(5):e14256. PubMed ID: 34472157
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
